Supreme Court Asked to Rule on Legality of Reverse Settlements
Executive Summary
For the third time the U.S. Supreme Court is being asked to determine whether reverse settlements between brand name and generic manufacturers are lawful. The case also will provide the Obama administration its first chance to weigh in on the issue
You may also be interested in...
Reverse Settlement Bill Clears House Subcommittee With GAO Report Attached
Legislation that would prohibit brand companies from compensating generic companies to delay entry of their generic drugs cleared the House Subcommittee on Commerce, Trade and Consumer Protection with a caveat: a Government Accountability Office report will keep tabs on whether the act results in earlier or delayed entry of generics to the market
Reverse Settlement Bill Clears House Subcommittee With GAO Report Attached
Legislation that would prohibit brand companies from compensating generic companies to delay entry of their generic drugs cleared the House Subcommittee on Commerce, Trade and Consumer Protection with a caveat: a Government Accountability Office report will keep tabs on whether the act results in earlier or delayed entry of generics to the market
Supreme Court Pick Sotomayor Lacks Rx Track Record, But Vioxx Case Looms
Those poring over Judge Sonia Sotomayor's rulings can get a sense of her views on civil rights, environmental law, privacy and the Second Amendment right to bear arms. But there seems to be no indication of how President Obama's nominee to the Supreme Court might rule on issues affecting the pharmaceutical industry